Beginning Cash: The amount of cash reported by the company on its previous statement.
Entera Bio Ltd. (ENTX) had Beginning Cash of $8.74M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-3.20M |
|
-- |
|
-- |
|
$3.26M |
|
$-3.26M |
|
$0.06M |
|
$-3.20M |
|
$-3.20M |
|
$-3.20M |
|
$-3.20M |
|
$-3.20M |
|
$-3.20M |
|
$-3.26M |
|
$-3.25M |
|
47.09M |
|
47.09M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$17.01M |
|
$0.11M |
|
$0.40M |
|
$17.41M |
|
$1.57M |
|
-- |
|
$0.60M |
|
$2.17M |
|
$15.23M |
|
$15.23M |
|
$15.23M |
|
45.66M |
|
| Cash Flow Statement Financials | |
$-5.54M |
|
$-0.08M |
|
$13.54M |
|
|
Beginning Cash |
$8.74M |
$16.69M |
|
$7.95M |
|
$2.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.62M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.01% |
|
-21.01% |
|
-18.38% |
|
-21.01% |
|
$0.33 |
|
$-0.12 |
|
$-0.12 |
|